Tags
- 10K
- A
- ACCE
- Acetylcholine
- Achievement
- Actual
- Administration
- Adult
- Ageing
- Ages
- Agriculture in the United States
- Alone
- America
- Amifampridine
- An
- Annual report
- Application
- Approval
- Approved
- Assist
- Assistance
- Autoimmune
- Autoimmune disease
- Best Of
- Biopharmaceutical
- Blocker
- Boxed
- Boxed warning
- Canada
- Caregiver
- Catalyst
- Catalyst Pharmaceuticals
- Cause
- CEO
- Channel
- Channel blocker
- Characterized
- Children
- CIII-DT
- Commerce
- Commercialization
- Commission
- Comprehensive
- Containment
- Coral
- Coral Gables, Florida
- Corticosteroid
- Dedicated
- Dedication
- Defined
- Described
- Designation
- Disease
- Disorder
- D.O.E.
- Dose
- Dosing
- Drug
- Drug discovery
- Drugs.com
- Duchenne
- Duchenne muscular dystrophy
- Dystrophy
- Epilepsy
- Exchange
- Exclusive
- Factor
- Familie
- Families
- Fast Track
- Fatigue
- FDA
- Filing
- Fiscal
- Fiscal year
- Flagship
- Flexibility
- Focus
- Food
- Food and Drug Administration
- For Children
- Form 10-K
- Forward-looking
- Forward-looking statement
- Four
- Gables
- Generalised tonic-clonic seizure
- Generalization
- Generalized epilepsy
- Globe
- GlobeNewswire
- Greater
- Health
- Health Canada
- Health care
- Healthcare providers
- Health professional
- Helps
- Impact
- Information Please
- Innovation
- In Treatment
- Involve
- J
- Journey
- Junction
- Known
- Known and Unknown: A Memoir
- Lambert–Eaton myasthenic syndrome
- Lawsuit
- Lems
- License
- Maximum
- Medicine
- Milestone
- Mission
- Muscle
- Muscle function
- Muscle weakness
- MUSCULAR
- Muscular dystrophy
- Myasthenia
- NASDAQ
- National Healthcare
- Need
- Needs
- Neuromuscular junction
- Neurotransmitter
- New
- New drug application
- New Level
- News agency
- Newsletter
- News resources
- North America
- Novel
- Number
- Obligation
- Offering
- Older
- Only
- Optimize
- Option
- Options
- Orphan
- Orphan drug
- Package insert
- Pathway
- Pathways
- Patient
- Pediatric patient
- Pediatrics
- Perampanel
- Periods.
- Pharmaceutical drug
- Phosphate
- Pivotal
- Potassium
- Potassium channel
- Potassium channel blocker
- Prescription
- Prescription drug
- Press release
- Primary
- Private Securities Litigation Reform Act
- Product
- Professional
- Provider
- Providers
- Reform
- Reform Act
- Regimen
- Regulation
- Regulatory agency
- Request
- Resource
- Result
- Richard J. Daly
- Rights
- Risk
- Safety
- Safety information
- SEC
- Securities and Exchange Commission
- Securities litigation
- Security
- Seizure
- Seizures
- Seventeen
- Six
- Six Years
- Source
- Speak
- Speech
- Statements
- Subscription business model
- Supplement
- Suspension
- Syndrome
- Tablet
- Term
- The best
- The Catalyst
- Today
- Topic
- Treat
- Treating
- Underscore
- Unknown
- U.S. Securities and Exchange Commission
- Visit
- Vulgar Display of Power
- Warning
- Weakness
- Weight